ICBA Statement on Tabled WTO TRIPS Waiver Text
Steve Bates, Chair of ICBA said “Now that the text is open to public scrutiny after its formal proposal by the WTO Director-General, it is clear that what is proposed would do nothing to solve
Here you’ll find the latest news articles and updates from the ICBA and the Biotech Industrty.
Steve Bates, Chair of ICBA said “Now that the text is open to public scrutiny after its formal proposal by the WTO Director-General, it is clear that what is proposed would do nothing to solve
Steve Bates Chair of ICBA said “The leaked QUAD proposal of a waiver on intellectual property rights for COVID vaccines would, if agreed, have a chilling impact on investment into the small companies that have
International Council of Biotechnology Associations
1201 New York Avenue NW Suite 1300
Washington, DC 20005
icba@bio.org